- Home
- TURN vs ATRA Comparison
TURN vs ATRA Comparison
Compare TURN & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- ATRA
- Stock Information
- Founded
- TURN 1981
- ATRA 2012
- Country
- TURN United States
- ATRA United States
- Employees
- TURN N/A
- ATRA N/A
- Industry
- TURN Finance/Investors Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TURN Finance
- ATRA Health Care
- Exchange
- TURN Nasdaq
- ATRA Nasdaq
- Market Cap
- TURN 33.4M
- ATRA 43.4M
- IPO Year
- TURN N/A
- ATRA 2014
- Fundamental
- Price
- TURN $3.21
- ATRA $9.05
- Analyst Decision
- TURN
- ATRA Hold
- Analyst Count
- TURN 0
- ATRA 6
- Target Price
- TURN N/A
- ATRA $24.88
- AVG Volume (30 Days)
- TURN 8.1K
- ATRA 86.9K
- Earning Date
- TURN 11-11-2024
- ATRA 10-30-2024
- Dividend Yield
- TURN N/A
- ATRA N/A
- EPS Growth
- TURN N/A
- ATRA N/A
- EPS
- TURN N/A
- ATRA N/A
- Revenue
- TURN $129,297.00
- ATRA $62,387,000.00
- Revenue This Year
- TURN N/A
- ATRA $1,190.80
- Revenue Next Year
- TURN N/A
- ATRA N/A
- P/E Ratio
- TURN N/A
- ATRA N/A
- Revenue Growth
- TURN 6.32
- ATRA 809.03
- 52 Week Low
- TURN $3.16
- ATRA $4.98
- 52 Week High
- TURN $4.47
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- TURN 31.67
- ATRA 59.48
- Support Level
- TURN $3.21
- ATRA $8.68
- Resistance Level
- TURN $3.28
- ATRA $10.05
- Average True Range (ATR)
- TURN 0.05
- ATRA 0.52
- MACD
- TURN -0.01
- ATRA 0.17
- Stochastic Oscillator
- TURN 25.67
- ATRA 64.91
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).